Russian Kogenate Pediatric Study

A Prospective Study to Evaluate the Effect of rFVIII-FS in Different Prophylactic Regimens on Bleeding Events Frequency and Development of Arthropathy in Previously Treated and Minimally Treated Hemophilia A Pediatric Population.

A prospective study to evaluate the effect of rFVIII-FS in different prophylactic regimens on bleeding events frequency and development of arthropathy in Previously Treated and Minimally treated Hemophilia A pediatric population.

Inclusion Criteria:

• Male
• Severe hemophilia A or moderate hemophilia A
• 1-12 years of age
• Requiring treatment with FVIII

Exclusion Criteria:

• Current or prior inhibitor or familial antecedents of inhibitor
• Surgery required during the study (9 months)
• Positive for HIV